Shares of Enzo Biochem Inc. (NYSE:ENZ) saw strong trading volume on Monday . 246,861 shares changed hands during mid-day trading, an increase of 17% from the previous session’s volume of 211,227 shares.The stock last traded at $6.03 and had previously closed at $6.36.

Separately, Zacks Investment Research cut shares of Enzo Biochem from a “buy” rating to a “hold” rating in a research report on Tuesday, August 9th.

The firm has a 50-day moving average of $6.39 and a 200-day moving average of $5.39. The company has a market cap of $277.58 million and a P/E ratio of 15.71.

Enzo Biochem (NYSE:ENZ) last released its quarterly earnings data on Wednesday, June 8th. The company reported ($0.04) EPS for the quarter, beating the consensus estimate of ($0.06) by $0.02. During the same period last year, the business earned ($0.07) earnings per share. The business had revenue of $18.16 million for the quarter, compared to analysts’ expectations of $24.50 million. On average, equities analysts anticipate that Enzo Biochem Inc. will post ($0.23) EPS for the current year.

Enzo Biochem, Inc (Enzo) is an integrated life science and biotechnology company, which is engaged in the research, development, manufacturing and marketing of diagnostic and research products based on genetic engineering, biotechnology and molecular biology. These products are designed for the diagnosis of and/or screening for infectious diseases, cancers, genetic defects and other medically pertinent diagnostic information and are distributed in the United States and internationally.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.